← FDA Drug Approvals (Drugs@FDA)

HYTRIN

NDA · New Drug Application · Sponsor: ABBOTT · Approved 1994-12-14

Drug application

FDA Application #

NDA020347

Application type

New Drug Application

Brand name

HYTRIN

Generic name

Terazosin Hydrochloride

Active ingredients

TERAZOSIN HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBOTT

First approval

1994-12-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown